TARUS THERAPEUTICS

Tarus Therapeutics is a provider of cancer therapy biotechnology services focused on nucleotide metabolism in cancer. The programs target the immunosuppressive adenosine pathway in the tumour microenvironment for the treatment of resistant cancers. They focused on nucleotide metabolism in cancer. The company's programs target the immunosuppressive adenosine pathway in the microenvironment for the treatment of resistant cancers, treating patients by suppressing immune cells in the tumor.